We are happy, to be a part of the #REPO4EU Community!
Hallo from Munich!! 👋 🇩🇪 The #REPO4EU consortium has arrived in the Bavarian city to celebrate the 4th #GeneralAssembly, hosted at Technische Universität München (Technical University of Munich)... there's a lot to catch up on before we officially kick off #RExPO24 tomorrow afternoon 🤩 If you're wondering what we've been up to, these are some of the crucial topics we've been discussing 👇 💊 Current status of the project, challenges and goals for next period (we're close to our 2nd anniversary already!) 💊 Crucial elements we need to implement for our #DrugRepurposing platform, with a big focus on #PatientNetworks and #RareDiseases 💊 A close first look at what our online platform will look like - lots of exciting developments happening in this area! 💊 Upcoming in-silico trials and potential new connections with further European #ClinicalData banks 💊 How to increase the impact of our research through ScienceOpen's Drug Repurposing Central (https://lnkd.in/ef4cCjaN) 💊 Location options for #RExPO25 next year!! Collaboration and knowledge exchange is at the heart of our project, and we're so fortunate to count on such a diverse pool of experts! As always, a big thank you to all the wonderful #REPO4EU partners for their continuous contributions and hard work towards shaping up the #FutureOfMedicine 🌟 Maastricht University, tp21 GmbH, Universität Wien, GeneSurge, STALICLA, Universität Hamburg, Technical University of Munich, Invicol GmbH, Sciomics, Universidad Politécnica de Madrid, DiHeSys - Digital Health Systems GmbH, H.M. Pharma Consultancy, Ipsis Pactis, AUSTRALO, Karolinska University Hospital, Brigham and Women's Hospital, Universitätsklinikum Bonn, Research Institute (RI), Arega Medical, Egnosis, 3D-PharmXchange, Radboudumc, Maastricht UMC , ScienceOpen, BioLizard, Universidade do Porto, Machine2Learn, a Silo AI Company and University of Zurich.